Loading...

Clarity

Guilherme Rocco

UX/UI Strategist with a strong focus on aligning user experience with business objectives. I help companies increase conversion, retention and product clarity through structured UX research, interface optimization and scalable design systems.

My approach combines data analysis, behavioral psychology and product strategy to transform digital interfaces into growth engines. I support founders, product leaders and marketing teams in solving usability bottlenecks, improving engagement metrics and building user-centered digital ecosystems.

Specialties: UX audits, CRO, Design Systems, Product Strategy, User Research, Interface Optimization.

$1.67/min

—
0 Calls

—

0 Reviews

—

Avg. call

Call me to talk about

Strategy

Strategic UX/UI consultant helping startups and established companies improve digital performance through experience design. I work at the intersection of product strategy, user behavior and conversion optimization, transforming complex journeys into intuitive and scalable systems.

Answers 2
Reviews 0

Answers

Guilherme Rocco answered

I am a UK-based designer of an innovative powered interior window shutter with smartphone control. I need funding to launch in the UK B2C

re deciding between validation capital (Kickstarter) and growth capital (Equity).

If your main risk is demand uncertainty, Kickstarter can validate the market while funding initial production.

If your main constraint is capital intensity (tooling, certifications, inventory, working capital), equity may be more appropriate.

For hardware in the UK B2C space, production readiness and certification timing are critical. Crowdfunding works best when operational risk is already minimized.

The decision should be driven by risk profile, not preference.

Schedule a call • Share • Flag

Crowdfunding

Equity Funding

Guilherme Rocco answered

Why is our Medical AI device failing to scale after successful pilots, despite securing major funding and hitting technical PMF?

You likely have clinical validation... not scalable adoption.

In Medical AI, pilots prove performance. Scaling depends on structural alignment:

1. Economic Buyer
Doctors liking it is insufficient. If the budget holder (hospital admin, procurement, payer) doesn’t see direct ROI, adoption stalls.

2. Incentive Structure
If reimbursement is unclear or financial upside isn’t explicit, usage plateaus after pilots.

3. Workflow Friction
Any added complexity in EHR/PACS integration or clinical workflow reduces expansion velocity.

4. Sales Repeatability
Pilot success is often founder-driven. Scaling requires a standardized, multi-stakeholder enterprise sales motion.

In short:
You solved for accuracy.
You haven’t fully solved for institutional economics and distribution.

Schedule a call • Share • Flag

Medical Devices

Go-to-market Strategy

Growth Strategies

Reviews

Member since February 2026